254 related articles for article (PubMed ID: 22612613)
1. The WHI: the effect of hormone replacement therapy on fracture prevention.
de Villiers TJ; Stevenson JC
Climacteric; 2012 Jun; 15(3):263-6. PubMed ID: 22612613
[TBL] [Abstract][Full Text] [Related]
2. Hormone replacement therapy in the post-Women's Health Initiative era. Report a a meeting held in Funchal, Madeira, February 24-25, 2003.
Burger H
Climacteric; 2003 May; 6 Suppl 1():11-36. PubMed ID: 12945798
[TBL] [Abstract][Full Text] [Related]
3. Lessons learned from the WHI: HRT requires a cautious and individualized approach.
Aubuchon M; Santoro N
Geriatrics; 2004 Nov; 59(11):22-6. PubMed ID: 15615157
[TBL] [Abstract][Full Text] [Related]
4. [Evidence of hormone replacement therapy for osteoporosis].
Tarakida A; Higuchi T; Mizunuma H
Clin Calcium; 2008 Oct; 18(10):1434-41. PubMed ID: 18830040
[TBL] [Abstract][Full Text] [Related]
5. [Postmenopausal hormonal treatment: conventional hormone replacement therapy or tibolone? Effects on bone].
Reginster JY
J Gynecol Obstet Biol Reprod (Paris); 2002 Oct; 31(6):541-9. PubMed ID: 12407324
[TBL] [Abstract][Full Text] [Related]
6. HRT, osteoporosis and regulatory authorities Quis custodiet ipsos custodes?
Stevenson JC;
Hum Reprod; 2006 Jul; 21(7):1668-71. PubMed ID: 16556675
[TBL] [Abstract][Full Text] [Related]
7. Long-term estrogen and hormone replacement therapy for the prevention and treatment of osteoporosis.
Levine JP
Curr Womens Health Rep; 2003 Jun; 3(3):181-6. PubMed ID: 12734027
[TBL] [Abstract][Full Text] [Related]
8. Effects of conjugated equine estrogen on risk of fractures and BMD in postmenopausal women with hysterectomy: results from the women's health initiative randomized trial.
Jackson RD; Wactawski-Wende J; LaCroix AZ; Pettinger M; Yood RA; Watts NB; Robbins JA; Lewis CE; Beresford SA; Ko MG; Naughton MJ; Satterfield S; Bassford T;
J Bone Miner Res; 2006 Jun; 21(6):817-28. PubMed ID: 16753012
[TBL] [Abstract][Full Text] [Related]
9. Recency and duration of postmenopausal hormone therapy: effects on bone mineral density and fracture risk in the National Osteoporosis Risk Assessment (NORA) study.
Barrett-Connor E; Wehren LE; Siris ES; Miller P; Chen YT; Abbott TA; Berger ML; Santora AC; Sherwood LM
Menopause; 2003; 10(5):412-9. PubMed ID: 14501602
[TBL] [Abstract][Full Text] [Related]
10. The impact of the Women's Health Initiative on hormone replacement therapy in a Medicaid program.
Hillman JJ; Zuckerman IH; Lee E
J Womens Health (Larchmt); 2004 Nov; 13(9):986-92. PubMed ID: 15665655
[TBL] [Abstract][Full Text] [Related]
11. Have we come full circle - or moved forward? The Women's Health Initiative 10 years on.
Langer RD; Manson JE; Allison MA
Climacteric; 2012 Jun; 15(3):206-12. PubMed ID: 22612605
[TBL] [Abstract][Full Text] [Related]
12. Hormone replacement therapy and cardiovascular disease revisited.
Stevenson JC
Menopause Int; 2009 Jun; 15(2):55-7. PubMed ID: 19465669
[TBL] [Abstract][Full Text] [Related]
13. Prevention and treatment of osteoporosis with hormone replacement therapy.
Christiansen C
Int J Fertil Menopausal Stud; 1993; 38 Suppl 1():45-54. PubMed ID: 8499959
[TBL] [Abstract][Full Text] [Related]
14. [Hormone replacement therapy and its derivatives in the prevention and treatment of osteoporosis].
Lamy O; Krieg MA
Rev Med Suisse Romande; 2002 Aug; 122(8):377-81. PubMed ID: 12357730
[TBL] [Abstract][Full Text] [Related]
15. The protective effect of hormone-replacement therapy on fracture risk is modulated by estrogen receptor alpha genotype in early postmenopausal women.
Salmén T; Heikkinen AM; Mahonen A; Kröger H; Komulainen M; Saarikoski S; Honkanen R; Mäenpää PH
J Bone Miner Res; 2000 Dec; 15(12):2479-86. PubMed ID: 11127213
[TBL] [Abstract][Full Text] [Related]
16. [Estrogens for treatment of osteoporoses].
Higuchi T; Tarakida A; Abe K; Mizunuma H
Nihon Rinsho; 2009 May; 67(5):954-9. PubMed ID: 19432116
[TBL] [Abstract][Full Text] [Related]
17. The role of menopausal hormone therapy in osteoporosis.
de Villiers T
Climacteric; 2007 Oct; 10 Suppl 2():71-3. PubMed ID: 17882677
[TBL] [Abstract][Full Text] [Related]
18. Is the estrogen controversy over? Deconstructing the Women's Health Initiative study: a critical evaluation of the evidence.
Harman SM; Naftolin F; Brinton EA; Judelson DR
Ann N Y Acad Sci; 2005 Jun; 1052():43-56. PubMed ID: 16024750
[TBL] [Abstract][Full Text] [Related]
19. Postmenopausal hormone therapy before and after the women's health initiative study: what consequences?
Mikkola TS; Clarkson TB; Notelovitz M
Ann Med; 2004; 36(6):402-13. PubMed ID: 15513292
[TBL] [Abstract][Full Text] [Related]
20. Design of the Women's Health Initiative clinical trial and observational study. The Women's Health Initiative Study Group.
Control Clin Trials; 1998 Feb; 19(1):61-109. PubMed ID: 9492970
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]